BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4964164)

  • 1. Bacteriological studies of bronchial secretions in 19 cases of cystic fibrosis.
    Feigelson J; Pecau Y
    Bibl Paediatr; 1967; 86():214-26. PubMed ID: 4964164
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):541-50. PubMed ID: 4153350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacteriologic surveillance of the sputum of 22 patients with mucoviscidosis].
    Feigelson J; Pecau Y
    Arch Fr Pediatr; 1967 Dec; 24(10):1135-47. PubMed ID: 5590823
    [No Abstract]   [Full Text] [Related]  

  • 4. L forms in patients with cystic fibrosis.
    Bruns WT; Brown BA
    Am Rev Respir Dis; 1970 Jun; 101(6):935-40. PubMed ID: 4986861
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery of Candida dubliniensis from sputum of cystic fibrosis patients.
    Peltroche-Llacsahuanga H; Döhmen H; Haase G
    Mycoses; 2002 Feb; 45(1-2):15-8. PubMed ID: 11856431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.
    Godard C; Plesiat P; Michel-Briand Y
    Eur J Med; 1993 Feb; 2(2):117-20. PubMed ID: 8258014
    [No Abstract]   [Full Text] [Related]  

  • 8. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbial findings in mucoviscidosis (author's transl)].
    Jedlicková Z; Vávrová V
    Cesk Epidemiol Mikrobiol Imunol; 1973 Nov; 22(6):338-44. PubMed ID: 4271764
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial flora in mucoviscidosis in relation to the clinical picture].
    Duroś H; Gierowska H; Golebiowska H; Kunicka A; Nowakowska A; Rutkowski J
    Przegl Epidemiol; 1972; 26(3):337-43. PubMed ID: 4628921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
    Marty N; Lapchine L; Pradere J; Dutau G
    Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective oral decontamination in cystic fibrosis: an attempt to prevent pseudomonas colonisation.
    Dalzell AM; van Saene HK; Heaf DP
    Acta Univ Carol Med (Praha); 1990; 36(1-4):40-1. PubMed ID: 2130715
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.
    Baltimore RS; Radnay-Baltimore K; von Graevenitz A; Dolan TF
    Helv Paediatr Acta; 1982; 37(6):547-54. PubMed ID: 6820015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility of bacterial isolates from patients with cystic fibrosis].
    García AD; Ibarra A; Rodríguez FC; Casal M
    Rev Esp Quimioter; 2004 Dec; 17(4):332-5. PubMed ID: 15696223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbiological study of the respiratory tract in children with cystic fibrosis].
    Muñoz C; Juncosa T; Gené A; Fortea J; Séculi JL; Latorre C
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):142-4. PubMed ID: 8695681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD; Laine L; Hughes S; Nicholson A; Galloway A; Gould FK
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.